ICUI - ICU Medical, Inc.
NASDAQ
->
Healthcare
->
Medical Instruments & Supplies
San Clemente,
United States
Type: Equity
ICUI price evolution
ICUI
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $254.22 | $197.19 | $195.89 | $220.95 |
| Short term investments | $0.5 | $1.81 | $1.81 | $3.23 |
| Net receivables | $161.57 | $161.8 | $162.22 | $139.46 |
| Inventory | $709.36 | $759.62 | $775.27 | $747.97 |
| Total current assets | $1221.27 | $1219.41 | $1244.74 | $1213.03 |
| Long term investments | ||||
| Property, plant & equipment | $682.82 | $682.53 | $692.57 | $703.85 |
| Goodwill & intangible assets | $2343.03 | $2335.74 | $2394.31 | $2420.41 |
| Total noncurrent assets | $3157.17 | $3157.46 | $3218.3 | $3257.61 |
| Total investments | $0.5 | $1.81 | $1.81 | $3.23 |
| Total assets | $4378.44 | $4376.86 | $4463.04 | $4470.63 |
| Current liabilities | ||||
| Accounts payable | $150.03 | $149.29 | $167.05 | $186.42 |
| Deferred revenue | ||||
| Short long term debt | $51 | $45.69 | $40.38 | $35.06 |
| Total current liabilities | $481.84 | $464.04 | $483.88 | $462.18 |
| Long term debt | $1577.77 | $1589.24 | $1600.72 | $1612.2 |
| Total noncurrent liabilities | $1773.19 | $1814.46 | $1864.35 | $1908.06 |
| Total debt | $1628.77 | $1634.93 | $1641.1 | $1647.26 |
| Total liabilities | $2255.03 | $2278.51 | $2348.23 | $2370.23 |
| Shareholders' equity | ||||
| Retained earnings | $807.85 | $824.99 | $817.75 | $827.69 |
| Other shareholder equity | -$53.08 | -$84.73 | -$48.79 | -$61.6 |
| Total shareholder equity | $2123.41 | $2098.36 | $2114.82 | $2100.4 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $254.22 | $208.78 | $552.83 | $396.1 |
| Short term investments | $0.5 | $4.22 | $14.42 | $14.69 |
| Net receivables | $161.57 | $225.26 | $105.89 | $124.09 |
| Inventory | $709.36 | $696.01 | $290.24 | $314.93 |
| Total current assets | $1221.27 | $1235.2 | $1029.81 | $920.78 |
| Long term investments | $0.52 | $4.62 | $12.97 | |
| Property, plant & equipment | $682.82 | $713.58 | $508.21 | $513.2 |
| Goodwill & intangible assets | $2343.03 | $2432.02 | $231.75 | $230.23 |
| Total noncurrent assets | $3157.17 | $3280.45 | $850.93 | $842.91 |
| Total investments | $0.5 | $4.74 | $19.04 | $27.66 |
| Total assets | $4378.44 | $4515.64 | $1880.74 | $1763.69 |
| Current liabilities | ||||
| Accounts payable | $150.03 | $215.9 | $81.13 | $71.86 |
| Deferred revenue | ||||
| Short long term debt | $51 | $29.69 | ||
| Total current liabilities | $481.84 | $494.56 | $200.78 | $195.49 |
| Long term debt | $1577.77 | $1625.53 | $2.07 | $2.4 |
| Total noncurrent liabilities | $1773.19 | $1931.15 | $63.93 | $65.94 |
| Total debt | $1628.77 | $1653.36 | ||
| Total liabilities | $2255.03 | $2425.71 | $264.71 | $261.43 |
| Shareholders' equity | ||||
| Retained earnings | $807.85 | $837.5 | $911.79 | $808.65 |
| Other shareholder equity | -$53.08 | -$121.76 | -$19.27 | -$1.52 |
| Total shareholder equity | $2123.41 | $2089.93 | $1616.03 | $1502.27 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $587.86 | $553.31 | $549.31 | $568.65 |
| Cost of revenue | $416.27 | $369.39 | $356.98 | $376.61 |
| Gross Profit | $171.59 | $183.92 | $192.33 | $192.04 |
| Operating activities | ||||
| Research & development | $22.41 | $20.87 | $22.3 | $19.76 |
| Selling, general & administrative | $154.62 | $148.61 | $150.9 | $152.57 |
| Total operating expenses | $187.76 | $176.64 | $185.55 | $183.35 |
| Operating income | -$16.17 | $7.28 | $6.78 | $8.7 |
| Income from continuing operations | ||||
| EBIT | -$12.27 | $18.81 | $1.26 | $9.13 |
| Income tax expense | -$19.53 | -$12.6 | -$12.93 | -$3.58 |
| Interest expense | $24.41 | $24.18 | $24.12 | $22.52 |
| Net income | ||||
| Net income | -$17.15 | $7.24 | -$9.93 | -$9.81 |
| Income (for common shares) | -$17.15 | $7.24 | -$9.93 | -$9.81 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2259.13 | $2280 | $1316.31 | $1271 |
| Cost of revenue | $1519.25 | $1582.24 | $824.82 | $809.51 |
| Gross Profit | $739.87 | $697.76 | $491.49 | $461.5 |
| Operating activities | ||||
| Research & development | $85.34 | $92.98 | $47.5 | $42.95 |
| Selling, general & administrative | $606.69 | $608.35 | $302.58 | $283.95 |
| Total operating expenses | $733.29 | $772.75 | $368.25 | $354.33 |
| Operating income | $6.58 | -$74.99 | $123.25 | $107.16 |
| Income from continuing operations | ||||
| EBIT | $16.92 | -$48.03 | $124.04 | $99.25 |
| Income tax expense | -$48.64 | -$40.12 | $20.05 | $10.62 |
| Interest expense | $95.22 | $66.38 | $0.86 | $1.75 |
| Net income | ||||
| Net income | -$29.66 | -$74.29 | $103.14 | $86.87 |
| Income (for common shares) | -$29.66 | -$74.29 | $103.14 | $86.87 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$17.15 | $7.24 | -$9.93 | -$9.81 |
| Operating activities | ||||
| Depreciation | $62.53 | $63.8 | $62.95 | $61.4 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $10.69 | $10.95 | $9.77 | $9.16 |
| Total cash flows from operations | $91.27 | $35.16 | -$1.47 | $41.24 |
| Investing activities | ||||
| Capital expenditures | -$31.95 | -$24.51 | -$19.03 | -$16.68 |
| Investments | $1.3 | $1.42 | $1.5 | |
| Total cash flows from investing | -$30.65 | -$24.51 | -$17.61 | -$15.18 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.79 | $2.06 | $0.17 | |
| Net borrowings | -$7.72 | -$7.68 | -$7.67 | -$7.58 |
| Total cash flows from financing | -$7.85 | -$6.4 | -$5.9 | -$15.84 |
| Effect of exchange rate | $4.26 | -$2.95 | -$0.08 | $1.94 |
| Change in cash and equivalents | $57.03 | $1.3 | -$25.06 | $12.16 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$29.66 | -$74.29 | $103.14 | $86.87 |
| Operating activities | ||||
| Depreciation | $250.68 | $258.8 | $99.29 | $94.85 |
| Business acquisitions & disposals | -$1844.16 | -$14.45 | ||
| Stock-based compensation | $40.56 | $36.02 | $27.34 | $23.95 |
| Total cash flows from operations | $166.2 | -$62.13 | $267.54 | $222.75 |
| Investing activities | ||||
| Capital expenditures | -$92.17 | -$98.34 | -$80.95 | -$94.21 |
| Investments | $4.22 | $33.04 | $4.72 | -$3.92 |
| Total cash flows from investing | -$87.95 | -$1909.47 | -$90.69 | -$98.14 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.02 | $8.79 | $9.37 | $13.19 |
| Net borrowings | -$30.65 | $1639.13 | -$0.61 | -$0.36 |
| Total cash flows from financing | -$35.98 | $1637.03 | -$16.87 | -$0.04 |
| Effect of exchange rate | $3.16 | -$9.48 | -$3.25 | $2.85 |
| Change in cash and equivalents | $45.44 | -$344.04 | $156.73 | $127.43 |
News
Fundamentals
| Market cap | $2.28B |
|---|---|
| Enterprise value | $3.66B |
| Shares outstanding | 24.14M |
| Revenue | $2.26B |
|---|---|
| EBITDA | $267.60M |
| EBIT | $16.92M |
| Net Income | -$29.66M |
| Revenue Q/Q | 1.70% |
| Revenue Y/Y | -0.92% |
| P/E ratio | -76.96 |
|---|---|
| EV/Sales | 1.62 |
| EV/EBITDA | 13.66 |
| EV/EBIT | 216.11 |
| P/S ratio | 1.01 |
| P/B ratio | 1.05 |
| Book/Share | 90.16 |
| Cash/Share | 10.53 |
| EPS | -$1.23 |
|---|---|
| ROA | -0.67% |
| ROE | -1.41% |
| Debt/Equity | 1.06 |
|---|---|
| Net debt/EBITDA | 7.48 |
| Current ratio | 2.53 |
| Quick ratio | 1.06 |